Erbitux MEtastatic Colorectal Cancer Strategy Study

Clinical trial NCT02484833 · COMPLETED

Trial details

NCT number: NCT02484833
Sponsor: Armando Orlandi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Antineoplastic Agents

Start date: 2015-02-01
Primary completion: 2019-12-01
Enrollment: 607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.